W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Compliance check done
No
Decision
P/0124/2023 : EMA decision of 14 April 2023 on the refusal of a modification of an agreed paediatric investigation plan for eculizumab (Soliris), (EMEA-000876-PIP03-14-M06)